title: Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.
abstract: We evaluated associations between reproductive and lifestyle risk factors with breast cancer tumor marker status in a case-control study. Cases were premenopausal women living in Vietnam and China who were eligible for a clinical trial of oophorectomy and tamoxifen as treatment for breast cancer (n = 682). Controls were nonrelative hospital visitors, matched on age to the cases (n = 649). Immunohistochemical analysis was used to identify the presence of estrogen receptor (ER) and progesterone receptor and the overexpression of HER-2/neu oncogene. Odds ratios (OR) and 95% confidence intervals (95% CI) were estimated using unconditional logistic regression, adjusted for known confounders. Overall, 280 (61%) tumor samples were ER positive and 176 (38%) were ER negative. HER-2/neu overexpression was detected in 161 (35%) samples, whereas 286 (26%) samples were HER-2/neu negative. We observed an inverse trend between increasing parity and decreasing breast cancer risk (P = 0.002). Women ages > or =25 years at first birth had increased breast cancer risk compared with women ages <25 years at first birth (OR, 1.53; 95% CI, 1.20-1.95). Women who consumed alcohol had increased risk of breast cancer compared with women who did not (OR,1.85; 95% CI, 1.32-2.61). Compared with controls, OR estimates for breast cancer by parity and age at first birth were significantly associated with ER and/or HER-2/neu tumor status by Wald test (P < 0.05). Family history, age at menarche, cumulative lactation, body mass index, and education were not significantly related to breast cancer risk. Our findings support the hypothesis that some breast cancer risk factors differ by ER and HER-2/neu tumor marker subtypes.
authors.affiliation: University of Wisconsin Comprehensive Cancer Center, Madison, WI, USA. hbnichols@wisc.edu
authors.forename: Hazel B
authors.initials: HB
authors.lastname: Nichols
authors.forename: Amy
authors.initials: A
authors.lastname: Trentham-Dietz
authors.forename: Richard R
authors.initials: RR
authors.lastname: Love
authors.forename: John M
authors.initials: JM
authors.lastname: Hampton
authors.forename: Pham Thi
authors.initials: PT
authors.lastname: Hoang Anh
authors.forename: D Craig
authors.initials: DC
authors.lastname: Allred
authors.forename: Syed K
authors.initials: SK
authors.lastname: Mohsin
authors.forename: Polly A
authors.initials: PA
authors.lastname: Newcomb
mesh_terms: D000328:Adult; D000428:Alcohol Drinking / Q000453:epidemiology; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001943:Breast Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D016022:Case-Control Studies; D002681:China / Q000453:epidemiology; D003131:Combined Modality Therapy; D005260:Female; D018734:Genes, erbB-2; D006801:Humans; D007407:Interviews as Topic; D008019:Life Style; D016015:Logistic Models; D008423:Maternal Age; D008875:Middle Aged; D010052:Ovariectomy; D010298:Parity; D017697:Premenopause; D011960:Receptors, Estrogen / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism; D012307:Risk Factors; D013629:Tamoxifen / Q000627:therapeutic use; D014744:Vietnam / Q000453:epidemiology
chemical_list: D014408:Biomarkers, Tumor; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D013629:Tamoxifen